Skip to main content
Professional Technical

pulmonary surfactant protein deficiency

Rare genetic disorder affecting surfactant protein production, causing severe neonatal and childhood respiratory disease.

Full Definition

Pulmonary surfactant protein deficiency encompasses rare genetic disorders affecting the production or function of surfactant proteins SP-B, SP-C, or ABCA3, which are essential for maintaining alveolar stability and gas exchange. These hereditary conditions can cause severe neonatal respiratory distress resembling hyaline membrane disease, or present later in childhood with interstitial lung disease patterns. SP-B deficiency is typically fatal without lung transplantation, while SP-C and ABCA3 deficiencies may have variable presentations and outcomes. Diagnosis requires genetic testing and specialized biochemical analyses, as conventional surfactant replacement therapy is often ineffective.

Usage

Usage note: Specify which surfactant protein is affected (SP-A, SP-B, SP-C, or ABCA3) when known; consider in familial cases or atypical presentations.

In Context

  • "Genetic testing confirmed pulmonary surfactant protein deficiency (SP-B) in the term infant with severe, persistent respiratory failure." — Genetics consultation report
  • "The family history of consanguinity raised suspicion for pulmonary surfactant protein deficiency in the affected neonate." — Specialist evaluation notes

Also known as

hereditary surfactant deficiency genetic surfactant disorders

Contrasted with

normal surfactant production adequate surface tension reduction

Don't confuse with

surfactant deficiency respiratory distress syndrome interstitial pneumonia

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON